Peripheral Arterial Disease (PAD) Therapeutics

Global Market Trajectory & Analytics

MCP-6815

EXECUTIVE ENGAGEMENTS

OUTREACH

2014
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

363
Interactions with Platform & by Email

PARTICIPANTS

62
Unique # Participated

VALIDATIONS

28
Responses Validated*

COMPETITORS

23
Responses Validated*

BRANDS

55
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

32

PAGES

85

EDITION

16

PRICE

USD $5450


  

HIGHLIGHTS

Amid the COVID-19 crisis, the global market for Peripheral Arterial Disease (PAD) Therapeutics estimated at US$776.4 Million in the year 2020, is projected to reach a revised size of US$1.1 Billion by 2027, growing at a CAGR of 4.7% over the period 2020-2027.
The Peripheral Arterial Disease (PAD) Therapeutics market in the U.S. is estimated at US$228.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$189.1 Million by the year 2027 trailing a CAGR of 4.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 3.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

SELECT PLAYERS

AstraZeneca Plc.; Bayer HealthCare Pharmaceuticals; Bristol-Myers Squibb Company; Merck & Co., Inc.; Proteon Therapeutics, Inc.; Sanofi S.A.; Symic Bio, Inc.; TheraVasc, Inc.

SEGMENTS

» Segment (Peripheral Arterial Disease (PAD) Therapeutics)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
PAD - A Prelude
Recent Market Activity
PAD Statistics
Critical Limb Ischemia - An Insight
High Costs - A Cause of Concern
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
AstraZeneca Plc. (UK)
Bayer HealthCare Pharmaceuticals (Germany)
Bristol-Myers Squibb Company (US)
Merck & Co., Inc. (US)
Proteon Therapeutics, Inc. (US)
Sanofi S.A. (France)
Symic Bio, Inc. (US)
TheraVasc Inc. (US)
3. MARKET TRENDS & DRIVERS
Aging - A Key Driver
High Diabetes Incidence Worldwide: Key Market Opportunity for PAD Therapeutics
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
CANADA
Canada Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
JAPAN
Japan Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
CHINA
China Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
EUROPE
Europe Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
GERMANY
Germany Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
ITALY
Italy Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UNITED KINGDOM
UK Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
REST OF EUROPE
Rest of Europe Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
REST OF WORLD
Rest of World Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Segment - Peripheral Arterial Disease (PAD) Therapeutics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Total Companies Profiled: 23

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com